(Q79280293)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17053806%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

title

Activation of CD95L fusion protein prodrugs by tumor-associated proteases (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17053806%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17053806%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

6

Pfizenmaier K

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17053806%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

author name string

Watermann I

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17053806%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Gerspach J

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17053806%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Lehne M

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17053806%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Seufert J

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17053806%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Schneider B

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17053806%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

publication date

20 October 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17053806%20AND%20SRC:MED&resulttype=core&format=json

Cell Death & Differentiation

20 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17053806%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17053806%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17053806%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

page(s)

765-774

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17053806%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.cdd.4402051

20 December 2019

exact match

0 references

cites work

Death receptors in chemotherapy and cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402051

7 January 2021

Tumor counterattack: fact or fiction?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402051

7 January 2021

Non-apoptotic Fas signaling.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402051

7 January 2021

Tumor therapeutics by design: targeting and activation of death receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402051

7 January 2021

Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402051

7 January 2021

Generation of a FasL-based proapoptotic fusion protein devoid of systemic toxicity due to cell-surface antigen-restricted Activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402051

7 January 2021

Restoration of membrane TNF-like activity by cell surface targeting and matrix metalloproteinase-mediated processing of a TNF prodrug

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402051

7 January 2021

TNF-Selectokine: a novel prodrug generated for tumor targeting and site-specific activation of tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402051

7 January 2021

Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402051

7 January 2021

Development of improved soluble inhibitors of FasL and CD40L based on oligomerized receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402051

7 January 2021

Tenascin-C hexabrachion assembly is a sequential two-step process initiated by coiled-coil alpha-helices

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402051

7 January 2021

CD95L/FasL and TRAIL in tumour surveillance and cancer therapy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402051

7 January 2021

Identifiers

DOI

10.1038/SJ.CDD.4402051

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17053806%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference